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Presently numerous recent drugs are products 
of nature or resulting from natural products, and 
nature is an auspicious source of treatments for 
new and emerging medical conditions (1-3). 
The search for treatments for diseases or 
infection from nature preceded the discovery of 
new technologies like ultra-high throughput 
screening (uHTS), targeted drug delivery (4-5) 
combinatorial chemistry, and genomic 
technology (6-9). Drug discovery from natural 
products has however been impacted 
significantly by the evolution of these new 
technologies, and there is an emerging 
perception that the role of natural products is 
starting to diminish (10-12). In spite of this, 
plants are still capable of yielding new 
bioactive compounds, and microbial organisms 
continue to yield novel structures and novel 
bioactivities. Since only 10% of the world's 
biodiversity has been studied for potential 
curative entities, the remainder is waiting to be 




Figure 1. Source of new Drugs 
The importance of natural products as a source 
of new drugs is shown in Figure 1, which 
documents the sources of all new drugs 
introduced between 1981 and 2010. The data 
clearly show the influence of nature in our 
discovery of new drug entities. About 29% of 
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the drugs were of synthetic origin, and the 
major portion of the remainder either were from 
natural products or were derived from natural 
products or the pharmacophore was from a 
natural origin. Therefore, the fact that most of 
the new drug entities are directly or indirectly 
linked to Mother Nature cannot be ignored. The 
linking of products from nature to modern 
combinatorial synthesis is also on the rise and 
older drugs with new indications are mainly 
drugs from natural products or are derivatives 
of natural products. For example, a study 
showed that compounds active on tumor cells 
(15) also exhibited anxiolytic properties and 
inhibited HIV reverse transcriptase.  
The major advantage of screening natural 
products is that they offer vast structural 
diversity, as compared with the more modest 
diversity obtained by combinatorial approaches. 
Materials and Methods 
The powdered air dried aerial parts of 
Cynanchum cutum L. was processed according 
to scheme 1. 
Study of Petroleum Ether Fraction 
The petroleum ether fraction (cf. scheme 1) was 
evaporated to dryness where a dark green 
residue was obtained. The residue was 
saponified using alcoholic sodium hydroxide. 
The un-saponifiable material was subjected to 
column chromatograph using silica gel. Three 
fractions were obtained by the solvent system 
hexane / EtOAc containing compound 1 at ratio 
of 49:1, compound 2 at 24:1 and compounds 3 
and 4 at 13:1. 
Characterization of Compound 1 
Thin- layer chromatographic study of 
compound 1 showed that it was not 
homogenous and contaminated with other 
minor constituents. Therefore, it was purified 
by preparative thin-layer chromatography, 
using silica gel and the same solvent system of 
CC (pet. ether / EtOAc 49:1). Compound 1 was 
obtained as white needles, m.p. 218-220
o
C, Rf 
= 0.24 (silica gel, pet. ether / chloroform 3:4). It 
gave a violet color upon spraying with p-
anisaldehyde sulphoric acid reagent indicating 
it's steroidal or triterpenoidal nature. 
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Figure 2. Scheme 1: Processing of Cynanchum acutum L. 
Results and discussion 
Characterization of Compound 1 
The IR spectrum revealed the presence of 





 (C=O group), 1252 cm
-1
 (C-O of 
acetate group). The 1H NMR spectrum (table 
4.1) revealed the presences of six methyl group 
signals in the up field region showing that the 
compound may be steroidal or triterpenoidal 
compound. The presence of two olefinic 
protons as broad singlets at 4.55 and 4.67 ppm 
is characteristic for pentacyclic lupane 
triterpene series (H-29, 29'). A down field H-3 
as double of doublet at δ 4.46 ppm indicates the 
probable link to an ester group and this was 
confirmed by the presence of acetoxyl group as 
singlet at 3.6 ppm. An olefinic methyl group as 
a broad singlet at 1.67 ppm was consistent to 
the C-30 methyl group. The H-19 appears as 
ddd at 2.38 ppm due to its allylic position. The 
Me-23 and 24 appear as singlets at 0.94, 0.76 
ppm, respectively. The spectrum indicated the 
presence of four tertiary methyl groups (Me-25, 
26, 27, and 28) as singlets at 0.83, 1.03, 0.96, 
0.79 ppm, respectively. Based on the previous 
spectral data, compound 1 which was isolated 
from unsaponifiable part is 3-O-acetyl lupane 
which was isolated previously from the same 






H NMR of compound 1 
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Characterization of Compound 2 
Compound 2 was isolated as white needle 
crystals, m.p. 211-213
o
C, Rf = 0.24 from (Silica 
Gel, pet. ether-chloroform 3:4). It gave a violet 
color upon spraying with p-anisaldehyde-
sulphoric acid reagent indicating it's steroidal or 
tri-terpenoidal nature. The IR spectrum (Fig 5) 
revealed the presence of absorption bands at 
3313 cm
-1
 (OH group), 2985 cm
-1
 (C-H 
stretching). The 1H NMR spectrum of 
compound 2 (table 1) is identical with the 1H 
NMR spectrum of compound 1 except the 
position of proton H-3. H-3 appears as double 
of doublet at a chemical shift 3.2 ppm which 
indicating that H-3 is attached to a free 
hydroxyl group characteristic for H-3 in sterols 
and triterpens. Thus compound 2 is lupan-3-ol 
which was isolated previously from the same 




H NMR of compound 2 
 
Structure Elucidation of Compound 3 
Compound 3 was obtained as white needles, 
m.p. 138-139
o
C; it gave a violet color upon 
spraying with p-anisaldehyde-sulphoric acid 
reagent indicating it’s steroidal or triterpenoidal 
nature. The 
1
H NMR spectra of compound 3 
(table 4.3) revealed the presences of six methyl 
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groups in the up field region showing that the 
compound is aliphatic and may be steroidal or 
triterpenoidal compound. The spectrum 
indicated the presence of a multiplet at δ 3.52 
ppm, which was assigned for H-3 indicating its 
steroidal nature. An olefinic proton appeared as 
broad singlet at 5.33 ppm, which was assigned 
for H-6 in ring B suggesting the presence of a 
Δ5 -3-hydroxy sterol. The spectrum indicated 
the presence of two tertiary methyl protons 
signals at 0.68, 1.01 ppm, corresponding to 
(Me-18 and Me-19) respectively. The side 
chain signals appeared at δ 0.92 (3H, d, J = 6.4 
Hz, Me-21), 0.83 (3H, d, J = 6.8 Hz, Me-26), 
0.81 (3H, d, J = 6.9 Hz, Me-27), 0.85 (3H, t, J = 
7.8 Hz, Me- 29) suggesting that the sterol has a 
stigmast-5-en-3-ol skeleton. Based on all these 
spectral data, compound 3 is β-sitosterol which 
was isolated previously from same plant species 




H NMR of Compound 3 
 
Structure Elucidation of Compound 4 
Compound 4 was isolated as white crystals; 
m.p 170
o
C also it gave a violet color upon 
spraying with p-anisaldehyde-sulphoric acid 
reagent indicating it's steroidal or triterpenoidal 
nature. The 
1
H NMR spectrum of compound 4 
(table 4) is identical with the spectrum of 
compound 3 in addition to two olefinic protons 
which appeared as double of doublet at δ 5.1, 
5.00 ppm, respectively, which were assigned 
for (H-22 and H-23). The spectrum suggesting 
the presence of a Δ5, 22 -3-hydroxy sterol. The 
H-20 and H-24 appeared as a multiplet at δ 2.24 
and 2.00 ppm, respectively due to their allylic 
position. Thus, all the previous data support 
that the compound 4 is stigmast-5, 22-dien-3-ol 
which is known as stigmasterol which was 
isolated previously from the same plant species 





H NMR of compound 4 
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